There are around 10,300 new bladder cancer cases in the UK every year (1). Our journey began by being one of them.
About ten years ago, one of the founders of Videometrics went through the bladder cancer patient care pathway and being an expert in image analysis, he immediately recognised that this was an area where our skillsets could help.
Therefore, the team here at Biosignatures partnered with the clinical experts at Newcastle Upon Tyne Hospitals (NUTH) and armed with their strengths and experience in urology and our strengths in visual perception, advanced imaging software plus a strong personal motivation, formed the Videometrics concept. An innovative, new medical device which we believe will revolutionise the management of bladder cancer.
With support from Innovate UK, we ran a study called CICERO (CANC 4362) which gained us direct access to the challenges clinicians face, and well as significant data to support our development of the system.
To keep up to date with the latest innovations check back regularly or email to find out more about our clinical studies: email@example.com.
References: 1. Cancer Research UK. Bladder cancer statistics. Available at: http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bladder-cancer#heading-Zero [Accessed July 2018]